Inside Washington: Medication Safety in the Limelight

by Jill Wechsler, BioPharm International FDA proposes bar codes on drug packages and new error reporting standards as part of its campaign to reduce medication errors.

Related Content:

Demonstrating the Consistency of Small Data Sets: Application of the Weisberg t-test for Outliers

Sumeria to Satellites: Evolution of the Bioreactor

Patent Law: Extracting Maximum Value from Your Patent Portfolio